We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

16 hedge funds and large institutions have $1.26M invested in Alterity Therapeutics in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

45% more funds holding

Funds holding: 11 → 16 (+5)

39% more capital invested

Capital invested by funds: $907K → $1.26M (+$352K)

0.72% more ownership

Funds ownership: 1.46% → 2.18% (+0.72%)

Holders
16
Holders Change
+5
Holders Change %
+45.45%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TLCM
Twin Lakes Capital Management
California
+$643K
2
HWM
HB Wealth Management
Georgia
+$282K
3
Citadel Advisors
Citadel Advisors
Florida
+$107K
4
GT
Greenleaf Trust
Michigan
+$72.4K
5
Morgan Stanley
Morgan Stanley
New York
+$50.1K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$537K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$4.25K
3
EWA
EverSource Wealth Advisors
Alabama
-$2.18K
Name Holding Trade Value Shares
Change 		Change in
Stake
TLCM
1
Twin Lakes Capital Management
California
$524K +$643K +133,333 +2,250%
Morgan Stanley
2
Morgan Stanley
New York
$258K +$50.1K +10,381 +18%
HWM
3
HB Wealth Management
Georgia
$220K +$282K +58,460 New
GT
4
Greenleaf Trust
Michigan
$120K +$72.4K +15,000 +88%
Citadel Advisors
5
Citadel Advisors
Florida
$83.5K +$107K +22,144 New
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$27.5K -$4.25K -881 -11%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$18K +$23.2K +4,799 New
RhumbLine Advisers
8
RhumbLine Advisers
Massachusetts
$3.34K +$3.65K +756 +582%
Citigroup
9
Citigroup
New York
$2.4K +$3.07K +636 New
Osaic Holdings
10
Osaic Holdings
Arizona
$889 – – –
EWA
11
EverSource Wealth Advisors
Alabama
$666 -$2.18K -451 -72%
BTI
12
Blue Trust Inc
Georgia
$150 – – –
FFA
13
Farther Finance Advisors
California
$83 +$106 +22 New
SPIA
14
Steward Partners Investment Advisory
New York
$23 – – –
DB
15
Danske Bank
Denmark
$4 – – –
SS
16
SBI Securities
Japan
$4 +$5 +1 New
Point72 Asset Management
17
Point72 Asset Management
Connecticut
– -$537K -131,431 Closed

ATHE Hedge Fund Activity: Q3 2025 in Review

16 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2025, worth a combined $1.26M — up 39% from $907K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ATHE positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Twin Lakes Capital Management, adding an estimated $643K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $537K sold.

  • 16 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2025, up from 11 in Q2 2025.
  • Funds reported $1.26M of Alterity Therapeutics stock for Q3 2025, up 39% quarter-over-quarter.
  • 6 funds opened new Alterity Therapeutics positions in Q3 2025 and 1 closed out, a net change of +5 holders.
  • The largest Alterity Therapeutics buyer in Q3 2025 was Twin Lakes Capital Management, an estimated $643K added.
  • The largest Alterity Therapeutics seller in Q3 2025 was Point72 Asset Management, an estimated $537K sold.

Based on aggregated 13F filings for Q3 2025.